Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker	Company	Revenue ▴	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
KYMR	Kymera Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$39.21M	-$311.35M	-794.0%	-19.7%	-16.7%	-$3.69
SGMOQ	Sangamo Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$39.55M	-$122.93M	-310.8%	n/a	-31.6%	-$0.44
VYGR	Voyager Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.37M	-$119.72M	-296.5%	-61.1%	-49.5%	-$2.04
EDIT	Editas Medicine, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.52M	-$160.06M	-395.0%	-586.6%	25.4%	-$1.80
FENC	Fennec Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$44.64M	-$9.74M	-21.8%	-27.5%	-6.1%	-$0.34
PLX	Protalix BioTherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$52.74M	-$6.60M	-12.5%	-13.7%	-1.2%	-$0.08
IVVD	Invivyd, Inc. Manufacturing · Year ended 2025-12-31 · USD	$53.43M	-$52.49M	-98.2%	-21.7%	110.5%	-$0.30
CSBR	Champions Oncology, Inc. Manufacturing · Year ended 2026-04-30 · USD	$59.42M	-$1.18M	-2.0%	-29.8%	4.4%	-$0.08
VIR	Vir Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$68.56M	-$437.99M	-638.9%	-57.2%	-7.6%	-$3.16
BDTX	Black Diamond Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$70.00M	$22.37M	32.0%	19.9%	n/a	$0.39
CGEN	Compugen Ltd Manufacturing · Year ended 2025-12-31 · USD	$72.76M	$35.34M	48.6%	34.4%	161.1%	$0.38
RXRX	Recursion Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$74.68M	-$644.76M	-863.4%	-57.0%	26.9%	-$1.44
AUTL	Autolus Therapeutics plc Manufacturing · Year ended 2025-12-31 · USD	$75.39M	-$287.53M	-381.4%	-161.4%	644.9%	-$1.08
MGTX	MeiraGTx Holdings plc Manufacturing · Year ended 2025-12-31 · USD	$81.39M	-$114.20M	-140.3%	n/a	144.6%	-$1.42
FDMT	4D Molecular Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$85.21M	-$140.11M	-164.4%	-27.7%	n/m	-$2.42
STRO	Sutro Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$102.48M	-$191.09M	-186.5%	n/a	65.2%	-$22.49
IPSC	Century Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$109.16M	-$9.58M	-8.8%	-6.0%	n/m	-$0.14
IBRX	ImmunityBio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$113.29M	-$351.40M	-310.2%	n/a	668.3%	-$0.38
AGEN	Agenus Inc Manufacturing · Year ended 2025-12-31 · USD	$114.20M	-$3.08M	-2.7%	n/a	10.4%	$0.00
ATRA	Atara Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$120.77M	$32.69M	27.1%	n/a	-6.3%	$2.57
GLUE	Monte Rosa Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$123.67M	-$38.63M	-31.2%	-16.6%	63.5%	n/a
BEAM	Beam Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$139.74M	-$79.99M	-57.2%	-6.5%	120.0%	-$0.81
DNA	Ginkgo Bioworks Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$170.16M	-$312.76M	-183.8%	-61.5%	-25.1%	-$5.64
RGNX	REGENXBIO Inc. Manufacturing · Year ended 2025-12-31 · USD	$170.44M	-$193.88M	-113.8%	-188.7%	104.5%	-$3.76
VXRT	Vaxart, Inc. Manufacturing · Year ended 2025-12-31 · USD	$237.26M	$16.33M	6.9%	18.6%	726.7%	$0.07

Rows per page: 2550 100